Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial. [electronic resource]
Producer: 20110623Description: 778-84 p. digitalISSN:- 1468-2060
- Biomarkers -- metabolism
- Bone Density -- drug effects
- Bone Density Conservation Agents -- adverse effects
- Double-Blind Method
- Drug Administration Schedule
- Female
- Glucocorticoids -- administration & dosage
- Hip Joint -- physiopathology
- Humans
- Lipids -- blood
- Lumbar Vertebrae -- physiopathology
- Middle Aged
- Osteoporosis, Postmenopausal -- chemically induced
- Prednisone -- administration & dosage
- Raloxifene Hydrochloride -- adverse effects
- Rheumatic Diseases -- drug therapy
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.